| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/10/2008 | US20080166350 Nucleotide sequences coding tumor associated antigens for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080166347 Human antibodies specific for interleukin 15 (IL-15) |
| 07/10/2008 | US20080166343 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 07/10/2008 | US20080166341 Cripto blocking antibodies and uses thereof |
| 07/10/2008 | US20080166337 Nucleotide sequences coding tumor associated differentially-expressed gene-12 (TADG-12) protein (serine protease) for use as tool in tissue targeted cancer therapy |
| 07/10/2008 | US20080166328 In vitro expansion of postpartum-derived cells using microcarriers |
| 07/10/2008 | US20080166327 Expanding hemangioblast in serum-free culture medium containingstem cell factor, interleukin-6, tyrosine kinase and thrombopoietin and recovering multipotent stem cells for use in treatment of ischemic cardiac disorders; tissue engineering; regenerative medicine |
| 07/10/2008 | US20080166326 Using tumor cells to induce targeted destruction by lymphocytes; tissue directed therapy |
| 07/10/2008 | US20080166325 Method of extensive culture of antigen-specific cytotoxic T cells |
| 07/10/2008 | US20080166324 Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use |
| 07/10/2008 | US20080166322 Using recombinant vector comprising defective e5 gene as tool for heterologous gene transfer; gene therapy |
| 07/10/2008 | US20080166319 Modified cytokine for use in treatment and prevention of viral infection, cell proliferative and autoimmune diseases |
| 07/10/2008 | US20080166300 Screening for agents that modulate a cancer associated phosphatase function; combining a candidate biologically active agent with a polypeptide having phosphatase activity; assessing the effectiveness on cancer cells |
| 07/10/2008 | US20080166295 Administering an antibody that selectively binds to the extracellular region of human magic roundabout (MR); inhibiting angiogenesis |
| 07/10/2008 | US20080166294 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/10/2008 | US20080164200 Filtration system and method for obtaining a cytology layer |
| 07/10/2008 | CA2674365A1 Foxp3 peptide vaccine |
| 07/10/2008 | CA2674123A1 Composition and method for enhancing cell growth and cell fusion |
| 07/10/2008 | CA2673944A1 Method for preparing pancreatic beta cells starting from beta cell progenitors and beta cells thereby obtained |
| 07/10/2008 | CA2673663A1 In vitro methods for the induction and maintenance of plant cell lines as single suspension cells with intact cell walls, and transformation thereof |
| 07/10/2008 | CA2670658A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 07/09/2008 | EP1942191A1 Nucleic acid construct containing full-length genome of human hepatitis C virus, recombinant full-length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 07/09/2008 | EP1942188A1 Recombinant viral proteins and particles |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942185A1 Method for production of carotenoid-synthesizing microorganism and method for production of carotenoid |
| 07/09/2008 | EP1942182A2 Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines |
| 07/09/2008 | EP1942179A1 Chip provided with film having hole pattern with the use of thermoresponsive polymer and method of producing the same |
| 07/09/2008 | EP1942116A1 Monoclonal antibodies for selective immunological regulation of high-molecular intact laminin forms in bodily fluids |
| 07/09/2008 | EP1942114A2 Mammalian cytokines; related reagents and methods |
| 07/09/2008 | EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism |
| 07/09/2008 | EP1941277A2 Marking composition based on biological vegetable materials |
| 07/09/2008 | EP1941041A1 Maize promoter active in silks, stalk nodes, roots and leaf sheaths |
| 07/09/2008 | EP1941032A2 Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype |
| 07/09/2008 | EP1941031A2 Isolated embryonic-like stem cells derived from human umbilical cord blood |
| 07/09/2008 | EP1941030A1 Cell migration assay |
| 07/09/2008 | EP1941029A2 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates |
| 07/09/2008 | EP1941028A2 Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes. |
| 07/09/2008 | EP1941027A1 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics. |
| 07/09/2008 | EP1941026A2 Methods of protein production using anti-senescence compounds |
| 07/09/2008 | EP1940871A2 Protease-resistant forms of vegf-d, method of making and method of use |
| 07/09/2008 | EP1940870A2 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 07/09/2008 | EP1940862A2 Allele-specific rna interference |
| 07/09/2008 | EP1940471A1 IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF |
| 07/09/2008 | EP1940460A2 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 07/09/2008 | EP1940457A2 Modified proteases that inhibit complement activation |
| 07/09/2008 | EP1940427A2 Encapsulation system |
| 07/09/2008 | EP1940424A2 Compositions and methods for the augmentation and repair of defects in tissue |
| 07/09/2008 | EP1940423A2 Tissue engineering methods and compositions |
| 07/09/2008 | EP1885844A4 Preparation and use of basement membrane particles |
| 07/09/2008 | EP1833961A4 Methods for culturing mammalian taste cells |
| 07/09/2008 | EP1472342B1 Oxa1p enhanced protein secretion |
| 07/09/2008 | EP1408109B1 Novel method for the induction of cellular senescence and method for screening anti-aging agent |
| 07/09/2008 | EP1403281B1 Novel ligand and dna thereof |
| 07/09/2008 | EP1226177B1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/09/2008 | EP1216306B1 Commercial production of chymosin in plants |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP1066392B1 Vectors for gene mutagenesis and gene discovery |
| 07/09/2008 | EP0832189B2 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 07/09/2008 | EP0783577B1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 07/09/2008 | EP0760851B1 Tumor necrosis factor receptor-associated factors |
| 07/09/2008 | EP0759170B1 Uses of green fluorescent protein |
| 07/09/2008 | CN101218348A Filamentous fungal mutants with improved homologous recombination efficiency |
| 07/09/2008 | CN101218346A Dehydrin genes and promoters from coffee |
| 07/09/2008 | CN101218342A 细胞滋养层干细胞 Cytotrophoblast stem cells |
| 07/09/2008 | CN101218341A Use of NK cell inhibition to facilitate persistence of engrafted MHC-I negative cells |
| 07/09/2008 | CN101218256A Antibodies against cd38 for treatment of multiple myeloma |
| 07/09/2008 | CN101218251A 异二聚体蛋白结合组合物 Heterodimeric protein binding compositions |
| 07/09/2008 | CN101215549A In vitro reforming method for erythrocyte blood type and special-purpose assorted agent for the same |
| 07/09/2008 | CN101215548A Human oocyte sequence vitrification refrigerating fluid and melting fluid |
| 07/09/2008 | CN101215547A Method for separating, purifying and extracting fat mesenchymal stem cell |
| 07/09/2008 | CN101215546A Method for obtaining inner ear hair cell precursor induced by bone marrow mesenchymal stem cells |
| 07/09/2008 | CN101215545A Method for obtaining neural progenitor cells induced by bone marrow mesenchymal stem cells |
| 07/09/2008 | CN101215544A Inflammation-inhibiting compounds |
| 07/09/2008 | CN101213942A Medicinal anoectochilus Formosan tissue culture one-step seedling establishment fast replication method |
| 07/09/2008 | CN101213941A Fast replication and in-vitro conservation method for dendrobium |
| 07/09/2008 | CN101213940A Fast replication method for dendrobium |
| 07/09/2008 | CN101213939A In-vitro high-frequency regeneration replication method of African chrysanthemum |
| 07/09/2008 | CN101213938A Method for cultivating detoxification tissue culture bulb of hyacinth |
| 07/09/2008 | CN101213937A Method for cultivating detoxification tissue culture bulb of fritillaria thunbergii |
| 07/09/2008 | CN101213936A Tissue culture fast breeding method for sandalwood |
| 07/09/2008 | CN100400666C Method for transferring bone marrow filling dry cell by TPO/FL |
| 07/09/2008 | CN100400662C Wild rice antifreeze gene and its coded protein and application |
| 07/09/2008 | CN100400655C Engineered extracellular matrix preparation method |
| 07/09/2008 | CN100400654C Glasswort tissue culture method and special culture medium |
| 07/09/2008 | CN100400653C Method for promoting cotton fiber extension |
| 07/09/2008 | CN100400547C Human monoclonal antibodies to prostate specific membrane antigen |
| 07/09/2008 | CN100400546C Cell surface molecule mediating cell adhesion and signal transmission |
| 07/08/2008 | US7396983 Soybean variety 4959932 |
| 07/08/2008 | US7396920 Tumour suppressor and uses thereof |
| 07/08/2008 | US7396916 Antibody to a polypeptide overexpressed in tumors |
| 07/08/2008 | US7396911 Preventing, treating, or ameliorating human immunodeficiency virus infection |
| 07/08/2008 | US7396910 Transient receptor potential channel TRPV3 and its use |
| 07/08/2008 | US7396907 Antibodies that bind PRO6182 polypeptides |
| 07/08/2008 | US7396906 Pro4399 Polypeptides |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396822 Comprising plasmid having open reading frame encoding antigen and linked eukaryotic expression sequence; immunostimulation by expressing heterologous genes |
| 07/08/2008 | US7396811 Subcellular targeting of therapeutic proteins |
| 07/08/2008 | US7396809 Methods and reagents for treating glucose metabolic disorders |
| 07/08/2008 | US7396682 Genetic engineered protein; joining mammals cells |
| 07/08/2008 | US7396681 Inducing an immune response by natural killer cells to increase cytolytic activity or stimulate cell proliferation by administering in or ex vivo a specific chaperone protein; treating cancerous, infectious and autoimmune diseases |